Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 132.0 | 57 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 135.0 | 60 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 140.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 187.0 | 40 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | LIF | 194.0 | 40 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 178.5 | 36 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | LIF | 182.0 | 49 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | LIF | 212.0 | 35 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | LIF | 221.0 | 26 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 43.5 | 50 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 51.0 | 36 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 50.0 | 50 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 51.5 | 48 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 41.0 | 47 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 61.0 | 48 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 68.0 | 45 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | LIF | 64.0 | 39 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 76.0 | 49 | |
N2645 | TNF-a | 100 | ng/mL | 4 | LIF | 95.0 | 50 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | LIF | 64.0 | 39 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | LIF | 65.0 | 39 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | LIF | 50.0 | 33 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | LIF | 49.0 | 31 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | LIF | 44.0 | 47 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | LIF | 42.5 | 34 |